Research Institute of Influenza by L. Tsybalova M. & L. Tsybalova M.
Volume 2     Number 1     2015                                     Microbiology Independent Research Journal p iv-v mir-journal.org
Dear readers, we dedicate this issue to the
Research Institute of Influenza
Deputy Director 
Dr. L.M. Tsybalova
Nowadays, the Russian Research Institute of Influenza is 
the only one in the world that is focused on the detailed 
research of Influenza and other Acute Respiratory 
Diseases (ARD).
A.A. Smorodintsev founded the Research Institute 
of Influenza and headed it from 1967 until 1972. 
Smorodintsev was a great virologist, famous all over 
the world for his influenza research. He was the first to 
succeed in isolating the influenza virus in Russia in 1934. 
In addition, Smorodintsev was the first who created the 
live attenuated vaccine against influenza [1, 2].
Some of the most important scientific innovations 
including the new ways of diagnostics have been made 
due to Smorodintsev’s research. Smorodintsev studied 
and evaluated the role of collective immunity during 
acute infections. He created the system of integrated 
prophylaxis against influenza by means of interferon 
inducers. He founded a clinic that specialized in the 
examination of influenza vaccines, immune-biological 
and etiotropic medicines. 
From 1973 until 1976 the Institute was headed by 
Prof. M.P. Zykov and then from 1976 until 1988 by Prof. 
G.I. Karpuhin.
From 1988 to now, the Institute has been led by the 
academician O.I. Kiselev. He was a renowned specialist 
in the field of molecular virology and biochemistry. In 
2004, he became a governmental award prize winner for 
his scientific contributions. 
Due to Kiselev’s ground-breaking research, the 
Institute has achieved outstanding progress in the sphere 
of the evolutional variability of the influenza virus strains. 
This research was carried out by Prof. T.Y. Luzianina and 
Prof. D.B. Golubev. Prof. P.Y. Poliak and Prof. Y.C. Shvarts-
man studied antiviral immunity. Prof. A.A. Sominina 
created main diagnostic preparations for viral infections. 
Prof. G.I. Alexandrova has created the first cold-adapted 
reassortant live influenza vaccine and studied the 
molecular mechanisms of virus attenuation. Later, the 
analogous vaccine was created and licensed in the US and 
Europe under the trade name FluMist®. During that time 
Prof. P.D. Starshov and Prof. D.M. Zlydnikov developed 
the new approaches for the etiotropic and pathogenetic 
therapy of severe and acute forms of Influenza and 
other ARD. Prof. V.I. Il’enko and Dr. V.G. Platonov made 
significant achievements in the creation and mechanism 
investigation of the new therapeutic and prophylactic 
medicines. Rimantadine is one of them. In the Institute’s 
clinic, the efficacy of rimantadine was demonstrated 
and the dosage and specific application schemes were 
developed. A team of virologists under the lead of Prof. 
A.S. Shadrin, Prof. L.G. Rudenko, and Prof. V.P. Drinevski 
have been focused on the evaluation of the live and 
inactivated influenza vaccines.
During the 1970s, the system of the epidemiological 
and etiological influenza surveillance was founded. The 
system enabled the prediction of seasonal epidemics 
throughout the Russian Federation (Prof. Y.G. Ivannikov 
and I.G. Marinich) 
Circa 1971 in the Research Institute of Influenza, the 
WHO National Influenza Centre began to work, focusing 
on the epidemiological and laboratory control for 
influenza and other acute respiratory infections. Since 
that time, the Russian Influenza surveillance system has 
been involved in the European Integrated Surveillance 
System (EISS). The Research Institute of Influenza serves 
as a training base for virologists and epidemiologists of 
the CIS and Eastern European countries involved in the 
EISS. 
The Institute has a collection of viruses starting 
since 1930 with more than 20,000 strains. The collection 
includes the reference strains and epidemic influenza 
viruses of A, B, and C types as well as other viruses 
inducing acute respiratory infections. This collection 
is integrated into the European Virus Archive (EVA). In 
addition to viruses, the collection includes over sixty 
items of the diploid and continuous cell lines. 
Currently, the research in the Institute of Influenza is 
conducted in several directions:
• Improvement of the epidemiological and etiological 
monitoring of influenza and other acute respiratory 
viral infections, the expansion of Russian Federation 
cooperation with the WHO.
• Molecular genetic and phylogenetic analyses 
of influenza viruses circulating in the country. 
Predicting the direction of the influenza virus 
variability and other viral agents.
• Identification of genetic determinants of the 
pathogenicity of existing and newly emerging viruses. 
The development of new methods for the isolation 
and taxonomy update for new viruses. 
• The study of the molecular mechanisms of the 
pathogenesis of viral infections. 
• Creating a new generation of diagnostic products. 
The development and implementation of new 
products for the diagnosis of viral infections, the 
characteristics of the cytokine status and other 
immunity factors. 
• The development of recombinant influenza proteins 
and vector vaccines, obtaining viral reassortants for 
traditional (“seasonal”) and pandemic influenza 
inactivated vaccines. 
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• Search and directed synthesis of new antiviral drugs 
of synthetic and natural origin. A comprehensive 
study of the mechanism of their inhibiting actions. 
• Preclinical and clinical studies of toxicity, 
immunogenicity, and protective efficacy for the 
prevention of viral infections. 
• The study of pathogenesis and improvement of 
treatment schemes of severe and complicated 
forms of influenza and other acute respiratory viral 
infections in adults and children. 
• The expansion of the collection of influenza and other 
respiratory viruses, cell cultures, and hybridomas for 
the production of monoclonal antibodies. Creation of 
electronic and printed catalogs. 
The Institute of Influenza is the research center 
and base for the training of highly qualified specialists 
(graduate and postgraduate traineeship) in three 
disciplines: Virology (03.02.02), Epidemiology (14.02.02) 
and Infection Diseases (14.01.09).
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